v" The clinical and histopathological characteristics in six cases of gonadotropin-producing adenoma are presented. Definitive diagnosis was made by the determination of gonadotropin levels in culture medium. Several authors have reported that gonadotropin-producing adenomas are very rare; however, hormonal assay of adenoma cell culture medium may indicate the real incidence of gonadotropin-producing adenomas to be greater than is thought. In reported cases, practically no endocrinological symptoms have been found suggesting increased gonadotropin levels, and basal values of plasma gonadotropins have been reported as only slightly over the normal range. Gonadotropin-producing adenomas may have been misdiagnosed as nonsecreting adenomas.
G
ONADOTROPIN-PRODUCING adenomas are considered a very rare entity among functioning pituitary adenomas. Several investigators have recently determined levels of gonadotropins (folliclestimulating hormone (FSH) and luteinizing hormone (LH)) in adenoma cell culture medium, and have studied adenoma cells histologically with an enzyme-labeled antibody technique. These technical advances should determine the real incidence of gonadotropin-producing adenomas: Only a few reports have considered the clinical features of these tumors. In this paper, we analyze the clinicopathological characteristics of six cases of gonadotropin-producing adenoma, verified by the determination of gonadotropins in culture medium.
Clinical Material and Methods
Clinical, radiological, and endocrinological studies were performed in six cases of gonadotropin-producing adenoma. Transsphenoidal removal of the adenoma was performed in each case, and the surgical specimen was preserved for histopathological examination by light and electron microscopy and by immunoperoxidase staining techniques.
Endocrinological Studies
Luteinizing hormone-releasing hormone (LH-RH) tests were performed before and after surgery. The results were compared with responses in 11 nonsecreting pituitary adenomas and four craniopharyngiomas obtained during the same period of time. The LH-RH test was started at 8:00 a.m. Blood was sampled once before and at 30, 60, 90, and 120 minutes after intravenous administration of 100 ~g LH-RH. Plasma testosterone was determined preoperatively. In three of the six cases, plasma testosterone was examined 24 hours after receiving four daily doses of 5000 IU human Gonadotropin-producing pituitary adenomas chorionic gonadotropin (HCG). Plasma estrogen was examined preoperatively in four cases.
Hormonal Assay in Culture Medium
Cell cultures were performed on five gonadotropinproducing adenomas, three growth-hormone (GH)-secreting adenomas, five prolactin-secreting adenomas, two adrenocorticotropin hormone (ACTH)-secreting adenomas, and one nonsecreting adenoma. Tumor cells were suspended in Eagle's minimal essential medium (MEM) containing 10% fetal bovine serum (FBS), then the suspensions (10 x 104 cells/ml) were cultured in a plastic tube at 37~ in 95% air/5% CO2 for 2 to 3 weeks. The culture medium was changed twice a week, and the hormonal assays were performed on the used medium.
Immunoperoxidase Staining
An immunoperoxidase technique was utilized for the cytological localization of adenohypophyseal hormones. Paraffin sections 4 to 6 um thick were made and immunostained by means of a DAKO PAP kit. Normal pituitary gland was used as a normal control, and normal rabbit serum instead of primary antibody serum constituted the negative control.
Electron Microscopic Examination
Electron microscopic examination was performed in Case 6. The surgical specimen was fixed for 2 hours in 3% glutaraldehyde in 0.1 M phosphate buffer at pH 7.4, and was then washed repeatedly in a 0.1 M phosphate buffer solution. Blocks of tissue were cut and placed in chilled 1% osmium tetroxide in phosphate buffer at pH 7.4, and left for 2 hours. After dehydration with graded ethanol solution, the tissue blocks were embedded in Epon 812 resin. Thin sections of the specimens were cut with an LKB ultratome III using a glass knife. The sections were mounted on uncoated copper grids, stained with uranyl acetate and lead citrate, and examined with a Hitachi H-300 electron microscope.
Results

Clinical Features
The total number of pituitary adenomas treated during the period of the study was 62 cases. The incidence of gonadotropin-producing pituitary adenoma was roughly 10%. Table 1 presents a summary of the clinical features of the six patients in this series. All of the patients were men, three of whom were aged over 60 years. All except one unmarried patient had had several children. Five of the six patients had visual disturbance as a chief complaint, and bitemporal visual field defects were found at the time of admission. Clinical symptoms related to hypogonadism were less frequent. Average interval between the onset of visual disturbance and admission was 3.75 months, although two patients had a longer delay due to inappropriate diagnosis. In comparison, delay to admission for patients with prolactinsecreting adenoma and bitemporal visual field defects was 3.2 months, and for patients with nonsecreting adenomas delay to admission was 18.4 months. Gonadotropin-producing adenomas appear to have a more rapid growth rate than nonsecreting adenomas.
Neuroradiological Examination
Prominent suprasellar extension on computerized tomography (CT) was observed in five cases. Gonadotropin-producing adenoma frequently showed an increased density on plain CT scans and enhanced intensively with contrast administration (Fig. 1) .
Endocrinological Studies
On LH-RH testing, basal FSH levels in plasma were slightly over the normal range for age in five patients. The basal plasma LH level was slightly over the normal range in three cases, and within normal range in three. In all cases, plasma FSH levels were higher than plasma LH levels: the levels of plasma FSH in response to LH-RH stimulation were normal or increased, but the plasma LH levels were lower than normal (Fig. 2 ). The peak FSH:peak LH ratio was over 1: l in four cases and under 1:1 in two cases of gonadotropin-secreting adenoma, under 1:1 in eight of 11 cases of nonsecreting adenoma, and under 1:1 in all cases of craniopharyngioma. Thus, it can be said that the gonadotropinproducing adenoma acts as an FSH-responding adenoma on LH-RH stimulation. Table 2 shows the levels of plasma testosterone and estrogen in our six cases. The levels of plasma testos- terone were under the normal range in five cases, but increased significantly after stimulation with 5000 IU HCG given intramuscularly for 4 days. There was no evidence for primary hypogonadism in these cases of gonadotropin-producing adenoma. Plasma estrone levels were over normal range in three cases, plasma estradiol levels were under normal range in three cases, and plasma estriol levels remained within normal range in all cases examined. Table 2 summarizes the surgical results. All patients underwent surgery via the transsphenoidal approach. Histological diagnosis with hematoxylin and eosin (H & E) staining was eosinophilic adenoma in all cases. Papillary structure of the adenoma was seen in five cases and sinusoidal adenoma was seen in one case.
Surgical Results
Perivascular rosette formation was observed in two cases. After operation, plasma FSH levels returned to normal in all except Case 1 and the response of LH to LH-RH was improved in half of the cases.
Hormonal Assay Results
Hormonal assays were performed on the culture media of the different adenomas examined (Table 3) . Levels of gonadotropins in the culture medium were higher in the cases of gonadotropin-producing adenoma than in the cases of other functioning or nonsecreting adenomas. The LH level was elevated the same amount as FSH only in one case, and FSH levels were disproportionally higher than LH levels in other cases. In all cultures, secretory activity in gonadotropin-producing adenomas did not seem as active as in other kinds of functioning adenomas. :~ Normal range for estrogen: estrone 36 _+ 10 pg/ml; estradiol 30 + 11 pg/ml: estriol < 10 pg/ml. ND = not done.
Light Microscopic Findings
Eosinophilic cytoplasm of the adenoma cells was revealed on H & E staining (Fig. 3 left) . In some adenoma cells, eosinophilic granules were seen; however, most of the adenoma cells had rather homogeneous eosinophilic cytoplasm.
Immunoperoxidase Staining
Immunoperoxidase staining disclosed the presence of immunoreactive FSH in the cytoplasm of tumor cells in all cases (Fig. 3 right) . Immunoreactive ACTH, GH, prolactin, and thyroid-stimulating hormone (TSH) was negative in all cases. Interestingly, immunoperoxidase staining for FSH showed some intensely and many faintly staining cells in all cases.
Electron Microscopic Findings
Ultrastructurally, most of the adenoma cells had irregular nuclei and prominent nucleoli. In a large number of adenoma cells, the cytoplasm contained many mitochondria but there were less secretory granules. These findings seemed to indicate an oncocytic transformation of the adenoma cells (Fig. 4 left) . The secretory granules present in every adenoma cell varied in electron density and size. They measured between 160 and 218 nm, and some of them had an electronlucent halo between the electron-dense core and the membrane of the granule. Mitochondria were usually rod-shaped with lamellar or cleft-like cristae (Fig. 4 right).
Discussion
The gonadotropin-producing adenoma has been considered a very rare entity, but since radioimmunoassay techniques were developed more gonadotropin-producing adenomas have been reported. There are several methods, such as hormonal assay of the culture media and enzyme-labeled antibody testing, which have been used to identify these cases. There have been few reports of the clinical findings. 
Etiology
Some authors have reported that gonadotropin-producing adenomas are caused by primary hypogonadism. ~'5"7"j6 They have postulated that the hypophyseal tumor might result from failure of the target organ and disturbance of the feedback mechanism to the hypothalamus. Such stimuli to the anterior pituitary lobe might first lead to anterior pituitary lobe hyperplasia and eventually to adenoma formation in some susceptible patients. On the other hand, other authors have reported cases of gonadotropin-producing adenoma not caused by primary hypogonadism. ~-3-9"~4 In differentiating gonadotropin-producing adenoma without primary hypogonadism from cases of primary hypogonadism, Snyder, et al., j2 reported that the administration of HCG would increase the plasma testosterone level only in cases of gonadotropin-producing adenoma without primary hypogonadism. They indicated that serum o~-subunit response to LH-RH was less than normal in cases of gonadotropin-producing adenoma and was greater than normal in cases of primary hypogonadism. They also indicated that the serum ~-subunit concentrations were much higher in cases of gonadotropinproducing adenoma, both before and after response to LH-RH, than in cases of primary hypogonadism. Primary hypogonadism was not observed in any of our six cases, and large increases in plasma testosterone levels after administration of HCG were observed in three cases. The five married patients with gonadotropin-producing adenoma in this study had children. With regard to pituitary enlargement caused by primary hypogonadism, Bower ~ reported that testosterone replacement alone was insufficient to adequately suppress gonadotropin secretion, and estrogen also played an important role in physiological regulation of gonadotropin secretion. Plasma estrogen may have some effect on the enlarging gonadotropin-producing adenoma; therefore, estrogen receptors in the cells of these tumors should be examined.
Clinical Features
The incidence of gonadotropin-producing adenomas in our total series of pituitary adenomas was 9.7% during the time of this study. This incidence seems higher than that given in previous reports. Snyder, et al., ~ examined gonadal function in 50 male patients with untreated pituitary adenoma and reported that selective hypersecretion of FSH often tended to be observed in men with pituitary adenoma. Takeuchi, et al., ~5 examined FSH in the culture medium of pituitary chromophobe adenomas, and pointed out that the secretion of FSH by chromophobe adenomas was more frequent than has previously been presumed.
It is quite obvious that gonadotropin-producing adenomas have been mistaken for nonsecreting adenomas because of lack of endocrinological symptoms, especially if basal values of gonadotropins are only slightly over normal range. Testing with LH-RH and the determination of FSH and LH in culture medium are necessary to identify gonadotropin-producing adenomas.
The major clinical symptom of visual disturbances has been reported before; however, gonadotropin-producing adenomas seem to grow more rapidly than nonsecreting adenomas. There are no endocrinological symptoms specific to FSH hypersecretion in the adult. Di Rocco, et al., 4 reported that precocious puberty was present in two children with gonadotropin-producing pituitary adenomas. There has never been any report on CT scanning of gonadotropin-producing adenomas. This is the first study reporting the CT appearance of gonadotropin-producing adenoma; the scans revealed remarkable suprasellar extension and marked contrast enhancement.
Endocrinological Findings
Basal plasma gonadotropins were only slightly elevated over the normal range, as previously reported; FSH and LH levels both increased in the culture medium in two cases, and only the FSH concentration increased in the other four cases. Snyder, et al.? 2 reported that 19 of 21 patients with pituitary adenoma, who had supranormal plasma gonadotropin levels, showed selective hypersecretion of FSH. It was presumed that gonadotropin-producing adenomas tended to selectively secrete FSH only. Kovacs, et al., 8 histopathologically analyzed two cases of pituitary adenoma with elevated blood FSH levels, and they speculated that certain pituitary tumors might arise in clones only secreting FSH or LH. They also suggested that the tumor cells might lose the potential to produce FSH and LH simultaneously while proliferating.
In our study, the response of LH to LH-RH stimulation in gonadotropin-producing adenomas was impaired, whereas the response of FSH was intact. This dissociated response of FSH and LH to LH-RH stimulation seemed to be one of the characteristic features of these tumors; however, gonadotropin-producing adenomas occur mostly in elderly men, so the aging effect on LH-RH stimulation must be taken into consideration. Snyder, et al., J3 stated that basal LH levels increased correspondingly with aging because of primary Leydig cell failure, but the change in basal FSH levels had nothing to do with age. They also reported that LH and FSH responses to LH-RH stimulation decrease in aging men. The peak FSH:peak LH ratio tends to be more frequently over 1:1 in gonadotropin-producing adenomas than is that of nonsecreting adenomas or craniopharyngiomas, and Takeuchi, et al., ~5 proposed that this is an endocrinological characteristic of gonadotropin-producing adenomas.
Histopathological Character&tics
In light microscopic examination of H & E-stained specimens, gonadotropin-producing adenomas appeared to have eosinophilic cytoplasm in all cases, although occasional eosinophilic granules were ob-served. Shirataki, et a/., ~~ reported that the pituitary oncocytoma was composed of granular eosinophilic cells with an organoid arrangement, and a distinguishing feature on electron microscopic examination was the presence of a great many mitochondria in the tumor cells. They indicated that the numerous mitochondria were the cause of oncocytic granularity in cytoplasm observed by light microscopy. The oncocytic transformation of adenoma cells was evident on the electron micrographs in our cases. In adenoma cells with oncocytic transformation, secretory granules were scant in number, and this finding could be the reason for plasma levels of gonadotropins slightly over the normal range. The finding of FSH in a small number of adenoma ceils with intense immunoperoxidase staining can also be explained by oncocytic transformation. Thus, either a determination of the gonadotropin level in culture medium or the histological examination of adenoma cells by means of an enzyme-labeled antibody method is required for the definitive diagnosis of gonadotropinproducing adenomas.
